Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary objective of the proposed study is to determine the difference in suturing time when using the restorelle Y mesh versus the restorelle dual flat mesh at the time of laparoscopic and robotic-assisted laparoscopic sacrocolpopexy.
Hypothesis: Suturing time when using the restorelle Y mesh will be faster than when using the restorelle dual flat mesh at the time of laparoscopic and robotic-assisted laparoscopic sacrocolpopexy.
Study Design: Randomized single-blind prospective clinical trial
Primary Outcomes:
Secondary Outcomes:
Post-operative patient outcomes at 24-months
Study Population: Study subjects will be recruited from patients that present to the Center of Urogynecology and Pelvic Floor Disorders in the Department of Obstetrics and Gynecology at the Cleveland Clinic main campus, Hillcrest Hospital and Fairview Hospital, and their surgeries will be performed at either one of these sites.
Study Procedures:
Study Identification and Recruitment Potential subjects will be identified by members of the Center for Urogynecology and Pelvic Reconstructive Surgery at the Cleveland Clinic main campus and Fairview Hospital. Eligible patients that agree to participate will be provided written informed consent administered by the collaborators listed on this Investigational Research Board (IRB) proposal at Cleveland Clinic Main campus and Fairview Hospitals.
Randomization All subjects will be predetermined by their surgeon to undergo either a laparoscopic or robotic assisted laparoscopic sacrocolpopexy depending upon their clinical evaluation. The participants will then be randomized to either Y mesh or dual flat mesh sacrocolpopexy according to a computer-generated randomization schedule with random block sizes with the use of the SAS statistical software package (SAS Institute, Cary, NC). Randomization will be carried out by provider. All patients will be blinded to their assignment.
Office Interventions In addition to a standardized evaluation including the history and physical examination, patients will be asked to complete the Pelvic Floor Distress Inventory (PFDI-20) questionnaire at the pre-operative visit as well as the 6, 12 and 24-month postoperative visit. Completion of these questionnaire is the only additional assessment that is specific to participation in this study and is not usually included as part of the standard care of sacrocolpopexy. It should take no more than 10-15 minutes to complete the questionnaire. The study subjects will not be exposed to any additional risk by participating in this study except for the inconvenience of completing the questionnaire.
Surgical Interventions Laparoscopic sacrocolpopexy will be performed using four ports: an umbilical port for the laparoscope, two ports (either 5 or 10/12 mm) in the bilateral lower quadrants, and one 5-mm port placed at the level of the umbilicus, lateral to the rectus muscle on either side for retraction. The robotic-assisted hysterectomy will be performed using the da Vinci Surgical System (Intuitive Surgical Inc., Sunnyvale, CA, USA) using five ports: a 12mm umbilical port for the laparoscopic, two 8 mm robotic ports placed 2cm inferior and 9-10cm lateral to the umbilicus bilaterally, an 8mm robotic port placed in the left axillary line at the level of the umbilicus, and a 8mm or 10/12mm accessory port either in the right upper quadrant approximately 3cm distal from the costal margin, or in the right lower quadrant, 2cm above and medial to the anterior superior iliac spine.
If a supracervical hysterectomy is to be performed, it will be done in a standard fashion. A uterine manipulator will be placed inside of the uterus. The round ligaments will be transected using cautery. The fallopian tubes and ovaries will be left in situ or removed at the time of hysterectomy depending upon the preoperative decision made between the surgeon and patient. The uterine arteries and cardinal ligaments will be cauterized laparoscopically. The uterus will be amputated at the level of the internal cervical os and the endocervical canal will be cauterized.
The sacrocolpopexy will also be performed and in a standard fashion. An end-to-end anastomosis (EEA) sizer will be placed in the vagina for manipulation of the apex as well as in the rectum for delineation of the rectovaginal septum. First, the presacral dissection will be performed with a longitudinal peritoneal incision over the sacral promontory and there is identification of the anterior longitudinal ligament. Dissection is then done caudally through the peritoneum and subperitoneal fat down to the level of the posterior cul-de-sac. The vagina is elevated cephalad using the EEA sizer and the peritoneum overlying the anterior vaginal apex is incised transversely, and the bladder is dissected off the anterior vagina using sharp dissection, creating a 4 to 5 cm pocket. If this plane is difficult to establish, the bladder will be filled in a retrograde fashion to find the correct dissection plane. Similarly, the peritoneum overlying the posterior vagina is incised, and dissection is then done overlying the vagina and extending into the posterior cul-de-sac, creating a 4 to 5 cm pocket. Once dissection is complete, the mesh graft is prepared. Subjects will have been randomized to either one of two mesh grafts:
Restorelle Y mesh
Restorelle dual flat mesh: 2 pieces of 15 x 4 cm mesh
The peritoneum is then closed over the exposed graft with absorbable suture. Routine cystoscopy will also be performed in order to assess for lower urinary tract injury. A vaginal exam is performed, and an anterior and/or posterior colporrhaphy and perineorrhaphy are performed if needed. Anti-incontinence procedures may also be performed if needed.
**In laparoscopic cases, all suturing will be done extracorporeally while intracorporeal knot-tying technique will be performed in robot assisted laparoscopic cases.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cololast, Inc. Restorell Y mesh | Active Comparator | Y mesh |
|
| Coloplast, Inc. Restorelle Dual flat mesh | Active Comparator | Dual flat mesh |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Y mesh | Device | Y mesh |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Total Suturing Time for Mesh Placement = Time From Insertion of Y Mesh or First Flat Mesh Arm Into Pelvis to Last Sacral Suture Placed | one day intraoperative | |
| Total OR Time = Operating Room Time of Entry and Exit | one day intraoperative |
| Measure | Description | Time Frame |
|---|---|---|
| Post-operative Mean Difference POPDI at 24 Months | Mean difference between baseline (pre-procedure) and 24-months post-procedure. The POPDI is a six-item measure from the PFDI-20 which measures 6 different pelvic organ prolapse symptoms and degree of bother. The scale exists from 0-100 (0=no symptoms, 100=worse symptoms). | 24 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Cecile Unger, M.D. | The Cleveland Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cleveland Clinic | Cleveland | Ohio | 44195 | United States |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Coloplast, Inc. Restorelle Y Mesh | Subjects implanted with Coloplast, Inc. Restorelle Y mesh at the time of minimally invasive sacrocolpopexy. |
| FG001 | Coloplast, Inc. Restorelle Dual Flat Mesh | Subjects implanted with Coloplast, Inc. Restorelle Dual flat mesh at the time of minimally invasive sacrocolpopexy. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Cololast, Inc. Restorell Y Mesh | Y mesh Y mesh: Y mesh |
| BG001 | Coloplast, Inc. Restorelle Dual Flat Mesh | Dual flat mesh Dual flat mesh: Dual flat mesh |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Total Suturing Time for Mesh Placement = Time From Insertion of Y Mesh or First Flat Mesh Arm Into Pelvis to Last Sacral Suture Placed | Posted | Mean | Standard Deviation | minutes | one day intraoperative |
|
|
Adverse events were collected up to 6 weeks after index surgery
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Coloplast, Inc. Restorelle Y Mesh | Y mesh Y mesh: Y mesh | 0 |
Not provided
Not provided
The biggest limitation in this study was lost to follow-up; however, this limitation was mitigated apriori by considering potential lost to follow-up in our power analysis.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Cecile Ferrando, M.D. | Cleveland Clinic | 216-444-0642 | ferranc2@ccf.org |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Aug 26, 2015 | Jul 8, 2020 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D011391 | Prolapse |
| ID | Term |
|---|---|
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Dual flat mesh | Device | Dual flat mesh |
|
|
| Postoperative Mean Difference CRADI at 24 Months |
Mean difference between baseline (pre-procedure) and 24-months post-procedure. The CRADI is a eight-item measure from the PFDI-20 which measures 8 different pelvic organ prolapse symptoms and degree of bother. The scale exists from 0-100 (0=no symptoms, 100=worse symptoms). |
| 24 months |
| Postoperative Mean Difference UDI at 24 Months | Mean difference between baseline (pre-procedure) and 24-months post-procedure. The UDI is a six-item measure from the PFDI-20 which measures 6 different pelvic organ prolapse symptoms and degree of bother. The scale exists from 0-100 (0=no symptoms, 100=worse symptoms). | 24 months |
| Postoperative Subjective Recurrence at 24 Months | Subjective Recurrence was defined as patients who complained of vaginal bulge symptoms (Question #3 on the PFDI-20). | 24 months |
| Postoperative Objective Recurrence at 24 Months | Objective Recurrence | 24 months |
| Reported Mesh Erosion at 24 Months | Mesh Erosion was defined as presence of eroded mesh in the vagina on examination postoperatively up to 24-months after surgery. | 24 months |
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Body Mass Index (BMI) | Mean | Standard Deviation | kg/m^2 |
|
| Tobacco use | Count of Participants | Participants |
|
| Parity | Median | Full Range | pregnancies |
|
| Prior prolapse surgery | Count of Participants | Participants |
|
| Prolapse Stage 1 | Patients who had Prolapse stage 1 based on POP-Q exam; this is a standardized measure. The most distal portion of the prolapse is >1 cm above the level of the hymen (i.e., its quantitation value is <-1 cm). Very mild prolapse - organs are still fairly well supported by the pelvic floor. | Count of Participants | Participants |
|
| Prolapse Stage 2 | Patients who had Prolapse stage 2 based on POP-Q exam; this is a standardized measure. The most distal portion of the prolapse is ≤1 cm proximal to or distal to the plane of the hymen (i.e., its quantitation value is ≥-1 cm but ≤+1 cm). Pelvic floor organs have begun to fall, but are still contained inside the vagina. | Count of Participants | Participants |
|
| Prolapse Stage 3 | Patients who had Prolapse stage 3 based on POP-Q exam; this is a standardized measure. The most distal portion of the prolapse is >1 cm below the plane of the hymen but protrudes no further than 2 cm less than the total vaginal length in centimeters (i.e., its quantitation value is >+1 cm but <+[TVL-2] cm). Pelvic floor organs have fallen to, or beyond the opening of the vagina. | Count of Participants | Participants |
|
| Prolapse Stage 4 | Patients who had Prolapse stage 4 based on POP-Q exam; this is a standardized measure. Essentially, complete eversion of the total length of the lower genital tract is demonstrated. The distal portion of the prolapse protrudes to at least (TVL-2) cm (i.e., its quantitation value is ≥+[TVL-2] cm). In most instances, the leading edge of stage IV prolapse is the cervix or vaginal cuff scar. Pelvic floor organs have fallen completely through the vaginal opening. | Count of Participants | Participants |
|
|
|
| Primary | Total OR Time = Operating Room Time of Entry and Exit | Posted | Mean | Standard Deviation | minutes | one day intraoperative |
|
|
|
| Secondary | Post-operative Mean Difference POPDI at 24 Months | Mean difference between baseline (pre-procedure) and 24-months post-procedure. The POPDI is a six-item measure from the PFDI-20 which measures 6 different pelvic organ prolapse symptoms and degree of bother. The scale exists from 0-100 (0=no symptoms, 100=worse symptoms). | Posted | Mean | Standard Deviation | score on a scale | 24 months |
|
|
|
| Secondary | Postoperative Mean Difference CRADI at 24 Months | Mean difference between baseline (pre-procedure) and 24-months post-procedure. The CRADI is a eight-item measure from the PFDI-20 which measures 8 different pelvic organ prolapse symptoms and degree of bother. The scale exists from 0-100 (0=no symptoms, 100=worse symptoms). | Posted | Mean | Standard Deviation | score on a scale | 24 months |
|
|
|
| Secondary | Postoperative Mean Difference UDI at 24 Months | Mean difference between baseline (pre-procedure) and 24-months post-procedure. The UDI is a six-item measure from the PFDI-20 which measures 6 different pelvic organ prolapse symptoms and degree of bother. The scale exists from 0-100 (0=no symptoms, 100=worse symptoms). | Posted | Mean | Standard Deviation | score on a scale | 24 months |
|
|
|
| Secondary | Postoperative Subjective Recurrence at 24 Months | Subjective Recurrence was defined as patients who complained of vaginal bulge symptoms (Question #3 on the PFDI-20). | Posted | Count of Participants | Participants | 24 months |
|
|
|
| Secondary | Postoperative Objective Recurrence at 24 Months | Objective Recurrence | Posted | Count of Participants | Participants | 24 months |
|
|
|
| Secondary | Reported Mesh Erosion at 24 Months | Mesh Erosion was defined as presence of eroded mesh in the vagina on examination postoperatively up to 24-months after surgery. | Posted | Count of Participants | Participants | 24 months |
|
|
|
| 30 |
| 0 |
| 30 |
| 0 |
| 30 |
| EG001 | Coloplast, Inc. Restorelle Dual Flat Mesh | Dual flat mesh Dual flat mesh: Dual flat mesh | 0 | 29 | 0 | 29 | 0 | 29 |
Not provided
Not provided
Not provided